184 related articles for article (PubMed ID: 16943437)
1. Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection.
Churikov D; Wei C; Price CM
Mol Cell Biol; 2006 Sep; 26(18):6971-82. PubMed ID: 16943437
[TBL] [Abstract][Full Text] [Related]
2. Pot1 and cell cycle progression cooperate in telomere length regulation.
Churikov D; Price CM
Nat Struct Mol Biol; 2008 Jan; 15(1):79-84. PubMed ID: 18066078
[TBL] [Abstract][Full Text] [Related]
3. Tetrahymena POT1a regulates telomere length and prevents activation of a cell cycle checkpoint.
Jacob NK; Lescasse R; Linger BR; Price CM
Mol Cell Biol; 2007 Mar; 27(5):1592-601. PubMed ID: 17158924
[TBL] [Abstract][Full Text] [Related]
4. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
5. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
[TBL] [Abstract][Full Text] [Related]
6. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.
Wu L; Multani AS; He H; Cosme-Blanco W; Deng Y; Deng JM; Bachilo O; Pathak S; Tahara H; Bailey SM; Deng Y; Behringer RR; Chang S
Cell; 2006 Jul; 126(1):49-62. PubMed ID: 16839876
[TBL] [Abstract][Full Text] [Related]
7. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells.
Gomez D; Wenner T; Brassart B; Douarre C; O'Donohue MF; El Khoury V; Shin-Ya K; Morjani H; Trentesaux C; Riou JF
J Biol Chem; 2006 Dec; 281(50):38721-9. PubMed ID: 17050546
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang.
Samper E; Goytisolo FA; Slijepcevic P; van Buul PP; Blasco MA
EMBO Rep; 2000 Sep; 1(3):244-52. PubMed ID: 11256607
[TBL] [Abstract][Full Text] [Related]
10. Apollo contributes to G overhang maintenance and protects leading-end telomeres.
Wu P; van Overbeek M; Rooney S; de Lange T
Mol Cell; 2010 Aug; 39(4):606-17. PubMed ID: 20619712
[TBL] [Abstract][Full Text] [Related]
11. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle.
Verdun RE; Crabbe L; Haggblom C; Karlseder J
Mol Cell; 2005 Nov; 20(4):551-61. PubMed ID: 16307919
[TBL] [Abstract][Full Text] [Related]
12. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes.
Zhu XD; Niedernhofer L; Kuster B; Mann M; Hoeijmakers JH; de Lange T
Mol Cell; 2003 Dec; 12(6):1489-98. PubMed ID: 14690602
[TBL] [Abstract][Full Text] [Related]
13. POT1 as a terminal transducer of TRF1 telomere length control.
Loayza D; De Lange T
Nature; 2003 Jun; 423(6943):1013-8. PubMed ID: 12768206
[TBL] [Abstract][Full Text] [Related]
14. Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.
Hockemeyer D; Daniels JP; Takai H; de Lange T
Cell; 2006 Jul; 126(1):63-77. PubMed ID: 16839877
[TBL] [Abstract][Full Text] [Related]
15. Identification of the determinants for the specific recognition of single-strand telomeric DNA by Cdc13.
Eldridge AM; Halsey WA; Wuttke DS
Biochemistry; 2006 Jan; 45(3):871-9. PubMed ID: 16411763
[TBL] [Abstract][Full Text] [Related]
16. Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle.
Pitt CW; Cooper JP
Nucleic Acids Res; 2010 Nov; 38(20):6968-75. PubMed ID: 20601686
[TBL] [Abstract][Full Text] [Related]
17. POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.
Zade NH; Khattar E
J Cell Physiol; 2023 Jun; 238(6):1237-1255. PubMed ID: 37183325
[TBL] [Abstract][Full Text] [Related]
18. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
19. POT1 and TRF2 cooperate to maintain telomeric integrity.
Yang Q; Zheng YL; Harris CC
Mol Cell Biol; 2005 Feb; 25(3):1070-80. PubMed ID: 15657433
[TBL] [Abstract][Full Text] [Related]
20. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.
Hockemeyer D; Sfeir AJ; Shay JW; Wright WE; de Lange T
EMBO J; 2005 Jul; 24(14):2667-78. PubMed ID: 15973431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
